Womens Health Investment Outlook 2026

The Women’s Health Investment Index2 With 90% of capital flowing into just three areas – women’s cancers, reproductive health and maternal health – this leaves significant white space in high-prevalence, high-burden conditions that affect women uniquely, differently and disproportionately. To better understand the overall investment landscape in women’s health, the Women’s Health Investment Index has been developed to provide an overview of private-sector investment activity between 2020 and 2025 across companies active in women’s health. It draws on leading commercial databases to map trends in mergers and acquisitions (M&A), minority stakes, private investments and public offerings (see Appendix A for the full methodology). For the purposes of this analysis, “women’s health” refers to conditions that affect women uniquely, differently or disproportionately. The analysis covered all identified companies active in women’s health, including those focused exclusively on women’s health conditions (“women’s health-specific companies”) and broader-based players with women’s health-specific assets. The results reveal a chronically undercapitalized market: small in scale, fragmented in structure and concentrated in a few familiar areas. Yet beneath the surface, the sector offers early signals of areas where targeted capital could unlock outsized returns. Women’s Health Investment Outlook 11